Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

Cholinergic drugs (acetylcholine and methacholine ... Tiotropium, the first-choice long-acting bronchodilator in COPD, has been studied in severe asthmatics and in COPD patients with a history ...

Purpose: The utilization of controller medications before initiating a long-acting β 2-adrenergic ... with a diagnosis of asthma, 37% with COPD, 65% with COPD and asthma, and 21% of patients ...

Medically reviewed by Brian Bezack, DOInhaler colors often are used to identify specific types of inhalers (such as blue for ...

This includes steroid-containing combinations and long-acting ... other COPD treatments, such as inhaled steroid-containing combination therapies," said Vasant Narasimhan, Global Head Drug ...

Medicare Part D and Medicare Advantage (Part C) plans with drug coverage ... inhalers for COPD. Some are short acting and intended for use when symptoms occur, while others are long acting and ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.